Lupin launches skin ointment in the US

Pharma Major Lupin said it launched Desoximetasone cream for treating skin problems in the US market.

The company had received approvals from the US Food and Drug Administration earlier.

The drug is the generic equivalent of Tarot Pharma’s Topicort, which had US sales of $38 million per year.

The drug is used for relief of the “inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.” Dermatosesa refers to lesions or eruptions of the skin that can be acute or chronic.

Lupin is the 6 largest generics pharmaceutical company by sales globally and the second biggest pharma company in India.

It manufactures branded & generic formulations, biotechnology products and APIs or active pharmaceutical ingredients. It focuses on Cardiovascular, Diabetology, Asthma, Pediatric, CNS, Gl, Anti-infective and NSAID space and has sales of 171,198 million (USD 2.55 bilion) per year.